These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 23678595)

  • 21. Paliperidone: quo vadis?
    Citrome L
    Int J Clin Pract; 2007 Apr; 61(4):653-62. PubMed ID: 17343660
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of continuous subcutaneous paliperidone infusion and repeated subcutaneous injection of risperidone free-base in rats.
    Marchese G; Pittau B; Casu G; Peddio G; Spada GP; Pira M; Deriu A; Portesani F; Pisu C; Lazzari P; Pani L
    Eur Psychiatry; 2010 Mar; 25(2):92-100. PubMed ID: 19640686
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Medication satisfaction in schizophrenia: a blinded-initiation study of paliperidone extended release in patients suboptimally responsive to risperidone.
    Canuso CM; Grinspan A; Kalali A; Damaraju CV; Merriman U; Alphs L; Awad AG
    Int Clin Psychopharmacol; 2010 May; 25(3):155-64. PubMed ID: 20216424
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Non-fatal paliperidone overdose: a case report].
    Gill JS; Pillai SK; Koh OH; Jambunathan S
    Turk Psikiyatri Derg; 2010; 21(4):331-4. PubMed ID: 21125508
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Measuring social functioning with the personal and social performance scale in patients with acute symptoms of schizophrenia: interpretation of results of a pooled analysis of three Phase III trials of paliperidone extended-release tablets.
    Patrick DL; Burns T; Morosini P; Gagnon DD; Rothman M; Adriaenssen I
    Clin Ther; 2010 Feb; 32(2):275-92. PubMed ID: 20206786
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment with paliperidone in children with behavior disorders previously treated with risperidone: an open-label trial.
    Fernández-Mayoralas DM; Fernández-Jaén A; Muñoz-Jareño N; Calleja-Pérez B; Fernández-Perrone AL; Arribas SL
    Clin Neuropharmacol; 2012; 35(5):227-30. PubMed ID: 22935606
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Paliperidone for treatment of schizophrenia.
    Nussbaum AM; Stroup TS
    Schizophr Bull; 2008 May; 34(3):419-22. PubMed ID: 18375569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Signalling profile differences: paliperidone versus risperidone.
    Clarke WP; Chavera TA; Silva M; Sullivan LC; Berg KA
    Br J Pharmacol; 2013 Oct; 170(3):532-45. PubMed ID: 23826915
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Paliperidone-ER: first atypical antipsychotic with oral extended release formulation.
    Lautenschlager M; Heinz A
    Expert Rev Neurother; 2008 Feb; 8(2):193-200. PubMed ID: 18271706
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimization of maintenance therapy of Risperidone with CYP2D6 genetic polymorphisms through an extended translational framework-based prediction of target occupancies/clinical outcomes.
    Li HQ; Xu JY; Gao YY; Jin L
    Pharmacol Res; 2018 Nov; 137():135-147. PubMed ID: 30281999
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacogenetic studies of response to risperidone and other newer atypical antipsychotics.
    Lane HY; Lee CC; Liu YC; Chang WH
    Pharmacogenomics; 2005 Mar; 6(2):139-49. PubMed ID: 15882132
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Different impacts of aquaporin 4 and MAOA allele variation among olanzapine, risperidone, and paliperidone in schizophrenia.
    Chung TS; Lung FW
    J Clin Psychopharmacol; 2012 Jun; 32(3):394-7. PubMed ID: 22544010
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risperidone in schizophrenia: is there a role for therapeutic drug monitoring?
    Seto K; Dumontet J; Ensom MH
    Ther Drug Monit; 2011 Jun; 33(3):275-83. PubMed ID: 21436762
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of iloperidone in the short-term treatment of schizophrenia: a post hoc analysis of pooled patient data from four phase III, placebo- and active-controlled trials.
    Citrome L; Meng X; Hochfeld M; Stahl SM
    Hum Psychopharmacol; 2012 Jan; 27(1):24-32. PubMed ID: 22161738
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Remission of drug-induced hepatitis after switching from risperidone to paliperidone.
    Paulzen M; Orfanos S; Gründer G
    Am J Psychiatry; 2010 Mar; 167(3):351-2. PubMed ID: 20194492
    [No Abstract]   [Full Text] [Related]  

  • 36. Neurotoxic/neuroprotective activity of haloperidol, risperidone and paliperidone in neuroblastoma cells.
    Gassó P; Mas S; Molina O; Bernardo M; Lafuente A; Parellada E
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Jan; 36(1):71-7. PubMed ID: 21878360
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An integrated approach for establishing dosing recommendations: paliperidone for the treatment of adolescent schizophrenia.
    Younis IR; Laughren TP; Wang Y; Mathis M; Gobburu JV
    J Clin Psychopharmacol; 2013 Apr; 33(2):152-6. PubMed ID: 23422374
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and efficacy of long-acting risperidone in schizophrenia: a 12-week, multicenter, open-label study in stable patients switched from typical and atypical oral antipsychotics.
    Lindenmayer JP; Eerdekens E; Berry SA; Eerdekens M
    J Clin Psychiatry; 2004 Aug; 65(8):1084-9. PubMed ID: 15323593
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A cross-sectional study of plasma risperidone levels with risperidone long-acting injectable: implications for dopamine D2 receptor occupancy during maintenance treatment in schizophrenia.
    Ikai S; Remington G; Suzuki T; Takeuchi H; Tsuboi T; Den R; Hirano J; Tsunoda K; Nishimoto M; Watanabe K; Mimura M; Mamo D; Uchida H
    J Clin Psychiatry; 2012 Aug; 73(8):1147-52. PubMed ID: 22967779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Forty years of antipsychotic Drug research--from haloperidol to paliperidone--with Dr. Paul Janssen.
    Awouters FH; Lewi PJ
    Arzneimittelforschung; 2007; 57(10):625-32. PubMed ID: 18074755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.